The Abuja Times

Lassa Fever Outbreak: Young Adults at Highest Risk as Nigeria Reports Over 1,000 Cases

The recent outbreak of Lassa fever in Nigeria has predominantly affected young adults, with the Nigeria Centre for Disease Control (NCDC) reporting 1,035 confirmed cases and 252 fatalities across 23 states.

T

The Abuja Times

Thu, 3 Sept 2026• 2 min read
Lassa Fever Outbreak: Young Adults at Highest Risk as Nigeria Reports Over 1,000 Cases
Lassa Fever Outbreak: Young Adults at Highest Risk as Nigeria Reports Over 1,000 Cases — The Abuja Times Newsroom

The Nigeria Centre for Disease Control (NCDC) has released alarming statistics regarding the ongoing Lassa fever outbreak in the country. Between August 10 and August 16, 2023, the NCDC confirmed a total of 1,035 cases and 252 deaths linked to the viral infection. This outbreak has predominantly impacted young adults, highlighting a concerning trend in the demographics affected by this disease.

According to the NCDC report, the confirmed cases were distributed across 23 states and 117 local government areas (LGAs), indicating a widespread issue that requires immediate attention and intervention. The data underscores the need for enhanced surveillance and public health measures to combat the spread of Lassa fever, particularly among vulnerable populations.

Lassa fever, which is endemic in Nigeria, is transmitted through contact with the urine or feces of infected rodents, and human-to-human transmission can occur as well. The disease often presents with symptoms that can be mistaken for other febrile illnesses, leading to delays in diagnosis and treatment. The current outbreak serves as a critical reminder of the importance of public awareness and education regarding the disease.

Health authorities are urging individuals, especially those in high-risk areas, to take preventive measures, such as maintaining good hygiene practices and avoiding contact with rodents. Additionally, the NCDC is working closely with local governments to implement effective control measures and to educate communities about the symptoms and risks associated with Lassa fever.

As the situation develops, it is imperative for the public to remain vigilant and informed. Timely reporting of suspected cases and prompt medical attention can significantly reduce the risk of severe outcomes. The NCDC continues to monitor the outbreak closely and will provide updates as more information becomes available.

Share this article with your network

Broadcast directly to WhatsApp communities and news circles.

Editorial Briefing

The Abuja Morning Dispatch

Get the capital's most important political investigations, cabinet decisions, and economic intelligence delivered to your inbox every morning.

No spam ever. Unsubscribe at any time with one click.

T

About The Abuja Times

Super Admin & Lead Director

Related Dispatches in Science & Tech

Bayelsa Introduces AI Robotic Tutors to Enhance Medical Education
Science & Tech
27 Oct•The Abuja Times

Bayelsa Introduces AI Robotic Tutors to Enhance Medical Education

In a groundbreaking initiative, the Bayelsa State government has unveiled AI robotic tutors at the state’s medical university, aiming to revolutionize medical training and research. This move underscores the government's commitment to integrating technology into education and improving healthcare outcomes in the region.

First Clinical Trial of Ebola Vaccine Launched in Democratic Republic of Congo
Science & Tech
24 Oct•The Abuja Times

First Clinical Trial of Ebola Vaccine Launched in Democratic Republic of Congo

The World Health Organization has initiated the first clinical trial of an Ebola vaccine amidst the ongoing outbreak in the Democratic Republic of Congo, which has claimed over 4,600 lives. The trial, named 'Tumaini,' aims to evaluate the effectiveness of the Ervebo vaccine against the Bundibugyo strain of the virus.

DR Congo Launches Hopeful Vaccine Trial Amidst Deadly Outbreak
Science & Tech
24 Oct•The Abuja Times

DR Congo Launches Hopeful Vaccine Trial Amidst Deadly Outbreak

The Democratic Republic of Congo has initiated a new vaccine trial named 'Tumaini' to combat the Bundibugyo virus, which has claimed over 4,600 lives. This trial represents a critical step in addressing the ongoing health crisis and developing effective preventive measures against the virus.